AGGF1 and colorectal carcinoma: Using Kaplan–Meier curves with a log-rank test for disease-free survival (DFS) and overall survival (OS), we assessed the predictive role of AGGF1 in CRC patient survival and found that patients with AGGF1-positive tumors had poorer DFS and OS rates than those with AGGF1-negative tumors (p < 0.05 for both, Fig. 2a-b).